Use of transgenic mice in UDP-glucuronosyltransferase (UGT) studies

By Ou Zhimin   Huang Min   Zhao Lizi   Xie Wen  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 123-131

Informa Healthcare

Access to resources Recommend Favorite

Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7

By Tsoutsikos P.   Miners J.O.   Stapleton A.   Thomas A.   Sallustio B.C.   Knights K.M.  

Biochemical Pharmacology, Vol. 67, Iss. 1, 2004-01 ,pp. : 191-199

Elsevier

Access to resources Recommend Favorite

Arbidol exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A9 and 2B7

By Liu Xin   Huang Ting   Chen Jian-Xing   Zeng Jia   Fan Xu-Ran     Yu Zhen-Wen   Sun Xiao-Yu   Hong Mo   Sun Hong-Zhi  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 12, 2013-12 ,pp. : 945-950

Govi-Verlag

Access to resources Recommend Favorite

Structure-inhibition relationship of podophyllotoxin (PT) analogues towards UDP-glucuronosyltransferase (UGT) isoforms

By Qi Jia-Qi   Cao Yun-Feng   Sun Xiao-Yu   Hong Mo   Fang Zhong-Ze   Meng Da-Li   Sun Dong-Xue  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 70, Iss. 4, 2015-04 ,pp. : 239-243

Govi-Verlag

Access to resources Recommend Favorite

Screening of non‐steroidal anti‐inflammatory drugs for inhibitory effects on the activities of six UDP‐glucuronosyltransferases (UGT1A1, 1A3, 1A4, 1A6, 1A9 and 2B7) using LC‐MS/MS

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 4, 2015-05 ,pp. : 258-264

John Wiley & Sons Inc

Access to resources Recommend Favorite